BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration
Yingying Zhang, Yang Li, Can Feng, Yunxin Yang, Ning Liang, Lili Qiao, Jian Xie, Yan Zhang, Pingping Hu, Guodong Deng, Jiandong Zhang · 2026
Read BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration by Yingying Zhang, Yang Li, Can Feng, Yunxin Yang, Ning Liang, Lili Qiao, Jian Xie, Yan Zhang, Pingping Hu, Guodong Deng, Jiandong Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13263866.txt.
Description
Yingying Zhang and colleagues tested in 2026 whether blocking a second immune brake, BTLA, strengthens radiation plus PD-1 therapy against lung cancer in mice. Database analysis first hinted that high BTLA marks tumors resisting immune treatment. Their experiments used a mouse lung tumor model treated with radiation and antibodies.
Radiation itself raised BTLA levels in tumor tissue, suggesting the brake engages under attack. Adding both antibodies to radiation shrank tumors more than either antibody pairing alone. Treated tumors filled with helper and killer T cells, and immune-activating cytokines rose. Removing memory B cells erased the benefit, exposing an unexpected supporting role for them. The triple combination thus worked partly by tuning those B cells to invite T cell entry. The authors offer the finding as a fresh angle for refining combined treatment.
Catalog record
| CREATOR | Yingying Zhang, Yang Li, Can Feng, Yunxin Yang, Ning Liang, Lili Qiao, Jian Xie, Yan Zhang, Pingping Hu, Guodong Deng, Jiandong Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |